A Specialized Practice Environment to Sharpen Clinical Fluency, Master Product Messaging, and Drive Continuous Improvement Through a Gamified Experience ACTO, a leader in AI-first commercial learning, enablement, and customer engagement solutions for life sciences and a Veeva Product Partner and member of the Veeva AI Partner Program, today announced the launch of CxZone, the first and…
Scopio’s Complete Blood Morphology (CBM®) ushers in a new era of lab automation, analyzing 10x more cells than the current standard of care in blood cell morphology, addressing global laboratory staffing crisis and accelerating hematology workflows and efficiencies Scopio Labs, developer of Full-Field Cell Morphology imaging and analysis platform, announced today the unveiling of its…
Compounds developed through collaboration with Variational AI show targeted activity Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced meaningful progress in its AI-driven KT-5000AI program, advancing the development of precision ATR (Ataxia Telangiectasia and Rad3-related) inhibitors designed to disrupt…
Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments in biotechnology, today announced that Vinicio Vargas, Chief Executive Officer (CEO) of Avant’s partner, Ainnova Tech, Inc., (Ainnova), was a featured speaker Friday and Saturday at Roche’s Latin America “Macular Spectacular” Ophthalmology conference in…
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. USA News Group News Commentary – The AI revolution in healthcare is fully underway, with the potential to save lives and money, but there’s still more to come. Healthcare startups are already figuring out how to implement AI to multiply their patients, and chase profits, to the benefit of investors. More Americans than…
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced the appointment of Jeff Fried to its Advisory Board. A recognized leader in healthcare data infrastructure and AI innovation, Jeff Fried brings more than 25 years of experience designing and…
New offering integrates Innovaccer’s Data Activation Platform with predictive analytics, care management workflows, and agentic AI capabilities to enable smarter, more scalable interventions Innovaccer Inc., a leading healthcare AI company, today announced the launch of a comprehensive, AI-powered Readmissions Management Solution designed to help health systems and providers reduce avoidable readmissions, standardize transitional care management (TCM) protocols,…
Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar disorders or schizophrenia Pre-Supplemental New Drug Application meeting with FDA scheduled for August 20, 2025 BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced the…
Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious…
Overture’s ICSI.A technology enabled first babies born from automated fertilization in 2023 Platform will now support one of the highest volume IVF clinics in the world at Memorial Hospital Istanbul, expected to assist in over 6,000 IVF cycles per year – and growing Overture Life, the innovator modernizing IVF to optimize reproductive freedom, announced the…